Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Effects of vancomycin and ciprofloxacin on the NMRI mouse metabolism
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4487283
Author(s) Liu, Zhigang; Xia, Bing; Saric, Jasmina; Utzinger, Jürg; Holmes, Elaine; Keiser, Jennifer; Li, Jia V.
Author(s) at UniBasel Utzinger, Jürg
Keiser, Jennifer
Saric, Jasmina
Year 2018
Title Effects of vancomycin and ciprofloxacin on the NMRI mouse metabolism
Journal Journal of Proteome Research
Volume 17
Number 10
Pages / Article-Number 3565-3573
Abstract The reduction in gut microbiota diversity is associated with a range of human diseases. Overuse of antibiotics has been associated with a diminished gut-microbial diversity in humans and may promote microbiota-associated negative effects to physical health, such as the metabolic syndrome-cluster of diseases and mental illnesses. There is a pressing need to deepen the understanding of the effects of antibiotics at the biochemical level. The current study investigated metabolic effects of two widely prescribed antibiotics-vancomycin and ciprofloxacin-on biofluids and brain tissue samples of NMRI female mice using a; 1; H nuclear magnetic resonance (NMR) spectroscopy-based metabolic profiling approach. While both antibiotics significantly affected the host metabolic signatures of urine and feces, only ciprofloxacin induced metabolic changes in plasma. Metabolic perturbations were pronounced 1 day post-treatment, reverting back to baseline at day 20 post-treatment. Both antibiotics induced changes in the choline metabolism, host-microbial cometabolites, short chain fatty acid production, and protein/purine degradation. The metabolic profiles of brain tissue aqueous extracts did not show any antibiotics-related changes by day 20 post-treatment. The data suggest that the metabolic disruptions in biofluids caused by antibiotics are reversed by day 20 post-treatment when compared to the pre-treatment profiles.
Publisher American Chemical Society
ISSN/ISBN 1535-3893
edoc-URL https://edoc.unibas.ch/66682/
Full Text on edoc No
Digital Object Identifier DOI 10.1021/acs.jproteome.8b00583
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30183313
ISI-Number WOS:000447118300022
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.353 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024